Entasobulin is primarily researched for its potential applications in the treatment of neurological disorders, particularly those involving cognitive impairment and memory loss. It has shown promise in preclinical studies for enhancing synaptic plasticity and improving cognitive functions, making it a candidate for addressing conditions like Alzheimer's disease and other forms of dementia. Additionally, its neuroprotective properties are being explored to mitigate the effects of neurodegenerative diseases. Researchers are also investigating its role in reducing inflammation in the brain, which could further support its use in treating brain injuries or chronic neurological conditions. Ongoing studies aim to determine its efficacy and safety in clinical settings.